Article info
PDFResponse
Psychotherapy is still failing patients: revisiting informed consent—a response to Garson Leder
- Correspondence to Dr Charlotte Blease, General Medicine and Primary Care, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02115, USA; cblease{at}bidmc.harvard.edu
Citation
Psychotherapy is still failing patients: revisiting informed consent—a response to Garson Leder
Publication history
- Received August 31, 2020
- Accepted September 5, 2020
- First published September 22, 2020.
Online issue publication
June 24, 2021
Article Versions
- Previous version (24 June 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.
Other content recommended for you
- Psychotherapy, placebos, and informed consent
- How to obtain informed consent for psychotherapy: a reply to criticism
- All you need is cognitive behaviour therapy?
- Cost and outcome of behavioural activation versus cognitive behavioural therapy for depression (COBRA): a qualitative process evaluation
- Talking more about talking cures: cognitive behavioural therapy and informed consent
- Comparative benefits and harms of second generation antidepressants and cognitive behavioral therapies in initial treatment of major depressive disorder: systematic review and meta-analysis
- Moving from tradition-based to competence-based psychotherapy
- Complementary therapies for clinical depression: an overview of systematic reviews
- Open therapy and its enemies
- Pharmacological and non-pharmacological treatments for major depressive disorder: review of systematic reviews